Results 251 to 260 of about 63,084 (277)

Spondyloarthritis

La Revue du praticien, 2022
Nilofar Syed, Fatemah Ezzati, Lesley Davila   +2 more
openaire   +3 more sources

Genetics of spondyloarthritis

Best Practice & Research Clinical Rheumatology, 2006
This chapter reviews evidence from family and twin studies supporting the strong genetic predisposition of the spondyloarthritides (SpA), which is only partially attributable to the major histocompatibility locus. The current concept of SpA heterogeneity has been challenged by family studies which showed that all articular and extra-articular ...
openaire   +2 more sources

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2022
Filip E Van Den Bosch, Denis Poddubnyy, Walter P Maksymowych   +2 more
exaly  

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis

Lancet, The, 2022
Jean W Liew, Maureen Dubreuil
exaly  

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Lancet, The, 2020
Atul Deodhar, Mrcp, Désirée M Van Der Heijde, Tae-Hwan Kim   +2 more
exaly  

Spondyloarthritis

Uria Shani, Abdulla Watad, Michael Ehrenfeld   +2 more
  +6 more sources

Axial spondyloarthritis

Lancet, The, 2017
Joachim Sieper, Denis Poddubnyy
exaly  

Spondyloarthritis

Aktuelle Rheumatologie, 2013
openaire   +1 more source

Ankylosing Spondylitis and Axial Spondyloarthritis

New England Journal of Medicine, 2016
Avneesh Chhabra, Robert A Colbert
exaly   +2 more sources

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

Lancet, The, 2018
Joachim Sieper, Philip J Mease, Atul Deodhar, Mrcp   +2 more
exaly